TY - JOUR T1 - Estimating effects of physical distancing on the COVID-19 pandemic using an urban mobility index JF - medRxiv DO - 10.1101/2020.04.05.20054288 SP - 2020.04.05.20054288 AU - Jean-Paul R. Soucy AU - Shelby L. Sturrock AU - Isha Berry AU - Duncan J. Westwood AU - Nick Daneman AU - Derek R. MacFadden AU - Kevin A. Brown Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/05/2020.04.05.20054288.abstract N2 - Governments have implemented population-wide physical distancing measures to control COVID-19, but metrics evaluating their effectiveness are not readily available. We used a publicly available mobility index from a popular transit application to evaluate the effect of physical distancing on infection growth rates and reproductive numbers in 40 jurisdictions between March 23 and April 12, 2020. A 10% decrease in mobility was associated with a 14.6% decrease (exp(β) = 0.854; 95% credible interval: 0.835, 0.873) in the average daily growth rate and a −0.061 (95% CI: −0.071, −0.052) change in the instantaneous reproductive number 2 weeks later. Our analysis demonstrates that decreases in urban mobility were predictive of declines in epidemic growth. Mobility metrics offer an appealing method to calibrate population-level physical distancing policy and implementation.One sentence summary An urban mobility index may be used as a proximal measure of COVID-19 case growth and reproductive number 2 weeks later.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this study.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and code to reproduce the analysis are available at: https://github.com/jeanpaulrsoucy/covid-19-mobility. This study used exclusively publicly available data (sources listed in the supplementary material).https://github.com/jeanpaulrsoucy/covid-19-mobility ER -